RxDoctor Payments Data

Wanda Taylor, DO

Family Medicine · Lexington, KYNPI 1720371883

Payments from drug & device makers

$292in general payments, 2019–2025

Across 9 payments — averaging $32.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Advanced Bionics, LLC$148
  • Tactile Systems Technology Inc$43
  • Indivior Inc.$26
  • Lilly USA, LLC$20
  • AbbVie$15
  • Amgen$14
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$292100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$292 in reported general payments places this provider in the 35th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$12,392
Medicare patients
45
Services billed
149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide51$45,880
EliquisApixaban112$40,874
MounjaroTirzepatide29$29,119
FarxigaDapagliflozin Propanediol39$21,270
TrulicityDulaglutide20$14,450
JanuviaSitagliptin Phosphate23$14,195
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$13,539
XareltoRivaroxaban33$10,609
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$8,378
TradjentaLinagliptin14$7,988
VascepaIcosapent Ethyl43$4,561
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen191$3,911
ArexvyRsvpref3 Antigen/As01e/Pf12$3,689
Donepezil Hcl64$3,325
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen102$3,182

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$20$43,56949 claims
AstraZenecaFarxiga$14$21,27039 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →